M. Alin

In vitro susceptibility of Tanzanian wild isolates of Plasmodium falciparum to artemisinin, chloroquine, sulfadoxine/pyrimethamine and mefloquine

M. Alin, 1997, Parasitology.

Population pharmacokinetic and pharmacodynamic modelling of artemisinin and mefloquine enantiomers in patients with falciparum malaria

M. Karlsson, M. Ashton, Y. Bergqvist, 2002, European Journal of Clinical Pharmacology.

The effect of artemisinin, its derivatives and mefloquine against chloroquine-resistant strains of Plasmodium falciparum in vitro

M. Ashton, A. Björkman, M. Alin, 1992 .

Efficacy of artemisinin and mefloquine combinations against Plasmodium falciparum. In vitro simulation of in vivo pharmacokinetics

W. Wernsdorfer, A. Björkman, M. Alin, 1997, Tropical medicine & international health : TM & IH.

Concentration and time dependency of artemisinin efficacy against Plasmodium falciparum in vitro.

A. Bjorkman, M. Alin, 1994, The American journal of tropical medicine and hygiene.

Efficacy of oral and intravenous artesunate in male Tanzanian adults with Plasmodium falciparum malaria and in vitro susceptibility to artemisinin, chloroquine, and mefloquine.

Z. Premji, A. Bjorkman, M. Ashton, 1995, The American journal of tropical medicine and hygiene.

Clinical efficacy and pharmacokinetics of artemisinin monotherapy and in combination with mefloquine in patients with falciparum malaria.

M. Ashton, A. Björkman, C. Kihamia, 2003, British journal of clinical pharmacology.

In vitro activity of artemisinin, its derivatives, and pyronaridine against different strains of Plasmodium falciparum.

M. Ashton, A. Björkman, M. Alin, 1990, Transactions of the Royal Society of Tropical Medicine and Hygiene.

Multiple dose pharmacokinetics of oral artemisinin and comparison of its efficacy with that of oral artesunate in falciparum malaria patients.

M. Ashton, A. Björkman, A Björkman, 1996, Transactions of the Royal Society of Tropical Medicine and Hygiene.